11 employees
Mycrodose Therapeutics is a pharmaceutical company specialized in the development of advanced drug delivery (ADD) systems
2020
Mycrodose Therapeutics raised undisclosed on September 21, 2021
Investors: K2 & Associates Investment Management Inc., Empath Ventures, Negev Capital, Ambria Capital, LLC, The Cannabis Fund and Receptor Partners, LLC